- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 146.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 197.5M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 143.39M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $2.74M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $2.76M |
| Capex | Q1 2026 · Mar 31, 2026 | $12.91M |
| Capex | Q1 2026 · Mar 31, 2025 | $13.55M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $19.28M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $23.31M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $895.7M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $884.9M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $70.74M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $69.32M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $85.17M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $90.21M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $85.91M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $141.94M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $155.11M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $499.28M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $517.78M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.66B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.68B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $394.77M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $389.18M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.8B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.84B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.12 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.14 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.05 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $150.78M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $167.52M |
| Net Income | Q1 2026 · Mar 31, 2026 | $19.89M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$7.33M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $327.35M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $356.62M |
| Revenue | Q1 2026 · Mar 31, 2026 | $548.49M |
| Revenue | Q1 2026 · Mar 31, 2025 | $571.57M |